Edition:
United States

People: Aceto Corp (ACET.OQ)

ACET.OQ on NASDAQ Stock Exchange Global Select Market

2.51USD
20 Apr 2018
Change (% chg)

$-0.15 (-5.64%)
Prev Close
$2.66
Open
$2.72
Day's High
$2.72
Day's Low
$2.50
Volume
516,346
Avg. Vol
153,673
52-wk High
$17.10
52-wk Low
$2.50

Kavuru, Vimal 

Mr. Vimal Kavuru has been appointed as Director, President of Rising of the Company, effective February 2nd, 2017. Mr. Kavuru founded Seller I and Seller II in 2013 and has served as the CEO of both companies since their inception. In 2008, Mr. Kavuru founded Gen-Source RX, a generic pharmaceutical distributor, and served as CEO until 2014 when that business was sold to Cardinal Health. Since 2007, Mr. Kavuru has served as a director of Celon Labs Ltd., an Indian specialty pharmaceutical company focused on the oncology and critical care segments in India that he co-founded in 2007. Additionally, he has served as a director of Cronus Pharma LLC, an animal health pharmaceutical company, since 2016, is the founder of Casper Pharma LLC, an emerging specialty brand and injectable pharmaceutical company, and is a co-founder of Grace Therapeutics, a pharmaceutical company focused on treating rare and orphan diseases.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --